European Medicines Agency - Regulatory - Regulation of medicines

6 -Public Involvement



    Description

Name

 

STAND4Kids - Supporting Pediatrics Trials in Portugal

Involvement of patients, parents or their organisations in the protocol design Yes YPAG Lisboa began its regular activities in late 2021. In 2023, the group provided input on the design of its first rheumatology trial study (not publicly available).
Involvement of patients, parents or their organisations in creating the protocol info package No YPAG Lisboa began its regular activities in late 2021. In 2023, the group provided input on the design of its first rheumatology trial study (not publicly available)., including protocol and patient-relevant information documents. Contributions to other studies are ongoing.
Involvement of patients, parents or their organisations in prioritisation of needs for Clinical Trials Yes YPAG Lisboa began its regular activities in late 2021. This includes discussions around needs and priorities. Other PPI activities of STAND4Kids include connecting with selected patient/family groups (over 10 dedicated meetings held, contribution to meetings organised by selected patient organizations or national stakeholders) and linking with EUPATI.